Medoxicam

Meloxicam, the active ingredient in Medoxicam, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients.

GNH USA supplies Medoxicam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID used to manage inflammatory joint diseases and acute pain. - Osteoarthritis: reduces joint pain and inflammation, improving mobility. - Rheumatoid arthritis: alleviates swelling and stiffness, helping preserve joint function. - Ankylosing spondylitis: diminishes spinal inflammation and pain, enhancing posture. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative states.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: mild swelling of the lower limbs. - Elevated liver enzymes: mild, transient increases.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Hepatotoxicity: significant liver injury. - Renal impairment: acute kidney injury or worsening chronic kidney disease.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Cardiovascular risk assessment: consider underlying heart disease before use. - Renal function monitoring: check serum creatinine and eGFR periodically. - Hepatic monitoring: perform liver function tests when indicated. - Avoid in patients with known hypersensitivity to oxicams or other NSAIDs. - Use caution in elderly patients due to increased susceptibility to GI and renal effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: meloxicam can raise lithium serum concentrations, risking toxicity.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may reduce renal function, especially in volume‑depleted patients. - Diuretics: combined use can impair kidney function. - Selective serotonin reuptake inhibitors (SSRIs): may modestly increase bleeding risk.